Broadcom Q2 FY2023 revenue $8.73B (+8% YoY), non-GAAP EPS $10.32; guides Q3 rev $8.85B

Broadcom Inc.

2023-Q2 EPS reported $16.95 revenue$17,648,000,000

Revenue $8,733M (+8% YoY); GAAP diluted EPS $8.15, non-GAAP diluted EPS $10.32.
Adjusted EBITDA $5,686M (65% margin); free cash flow $4,380M.
Repurchased 5.6M shares for $3,420M during the quarter.
Q3 FY2023 revenue guidance ~$8,850M (+5% YoY); adjusted EBITDA margin ~65%.
Quarterly dividend of $4.60 per share declared, payable June 30, 2023 to record holders June 22.

item 2.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.98

Broadcom Inc. reported second fiscal quarter ended April 30, 2023 results: revenue $8,733 million, net income $3,481 million (GAAP); $4,489 million (Non-GAAP), EPS $8.15 per diluted share (GAAP); $10.32 per diluted share (Non-GAAP). Guidance initiated.

Period: second fiscal quarter ended April 30, 2023
Revenue: $8,733 million
Net income: $3,481 million (GAAP); $4,489 million (Non-GAAP)
EPS: $8.15 per diluted share (GAAP); $10.32 per diluted share (Non-GAAP)
Guidance: initiated
Result: reported results

Exact text from the filing

Exchange Act of 1934, as amended. --- EX-99.1 (EX-99.1) --- Broadcom Inc. Announces Second Quarter Fiscal Year 2023 Financial Results and Quarterly Dividend • Revenue of $8,733 million for the second quarter, up 8 percent from the prior year period • Adjusted EBITDA of $5,686 million for the second quarter • Non-GAAP diluted EPS of $10.32 for the second

View on SEC.gov

309 earnings releases filed in the last 30 days. Browse all earnings releases →

Broadcom Inc. filing history →

Source: SEC EDGAR

accession 0001730168-23-000062

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.